TECHNOLOGY
NT2
(Nutrient Transport Technology™ )
Foul-taste isolation, triggered & sustained release, solubility/ bioavailability enhancing, micro-encapsulation technology
- Notoriously foul taste at negligible dosing
- Compromised bioavailability
- Spike & crash phenomena
- Gastrointestinal side-effects
- Negative impact on texture and shelf-life
- Mismatch with manufacturing and logistics SOPs
NT2 - sub 250μ micro-encapsulated powder, optimized for delivery within food and beverage products
An innovative, multi-layered micronized particle, enabling the delivery of sophisticated pharma-class properties in food and beverage products:
ATTRIBUTES
-
Optimal dispersion in liquid formulations
- Hydrophilic(“water-loving”) microencapsulation shell facilitate homogeneous dispersion in beverage and liquid formulations
-
Microencapsulated particles under 250 microns
- Particle size below the sensory threshold of the human mouth
- Inner shell layer controls sophisticated sustained-release profiles
- Outer shell layer controls release triggerss
-
Enhanced water solubility
- Enhancing the solubility of low-bioavailability natural actives
-
Array of sustained-release profiles
- From burst (1h release) to prolonged sustained release (12h)
- In a single formulation, providing each natural active a different release profile, based on its pharmacokinetics
-
Delivery in high water-content food & beverage products
- Lag-time after reconstruction ensures delayed actives’ release, only after consumption
BENEFITS
-
High-dose formulations (15 – 60 pills equivalent)
- Supporting high and effective dosing, up to X30 from current limitations
- High dosing does not compromise positive consumption
-
Complete foul-taste isolation
- A new era of effective microencapsulating, replacing ineffective taste masking
-
Standardizing low-quality botanicals
- Converting low-quality challenging botanical extracts to consistently-performing bioactives with an array of potential pharma-class properties
-
Stability during manufacturing and logistics SOPs
- No modifications required to standard manufacturing SOPs
- No special requirements during logistic transport
-
Consumer-recognized Impact
- Nootropic (brain-impacting) actives enable 15 – 30 minutes to consumer-sensed and recognized impact
- The impact of adaptogens can span between a few hours and a few days, typically depending on the required bioactive “loading” period only after consumption
Final particles in a 250 microns scale-factor
![](https://www.vitaltech.bio/wp-content/uploads/2021/05/sphere.png)
- Bioavailability enhancing matrix
- Sustained-release control
- Water resistance & disintegration trigger control
MAIN CAPABILITIES
![](https://www.vitaltech.bio/wp-content/uploads/2021/05/1-1.png)
CONTROLLED & SUSTAINED RELEASE
Condensing pharma-class triggers & sustained-release properties into sub 250μ particles
![](https://www.vitaltech.bio/wp-content/uploads/2021/05/2-1.png)
ISOLATE
Multiple shell layers resistant to water, isolating the foul taste of natural actives even at high dosing levels
![](https://www.vitaltech.bio/wp-content/uploads/2021/05/3-1.png)
OPTIMAL DISPERSIBILITY
Sophisticated outer shell layer supporting homogeneous “free-float” distribution in liquid formulations
![](https://www.vitaltech.bio/wp-content/uploads/2021/05/4-1.png)
LONG-TERM STABILITY
Microcapsules containing preventive actives prevent release in food & beverage products until encountering GI tract conditions
NT2 microencapsulated controlled and sustained release
Example- Extending the caffeine impact for up to 12 hours
15M LAG-TIME; FULL RELEASE IN 60M (1 HOUR)
30M LAG-TIME; FULL RELEASE IN 240M (4 HOURS)
45M LAG-TIME; FULL RELEASE IN 600M (10 HOURS)
![](https://www.vitaltech.bio/wp-content/uploads/2021/05/grafic.png)
Certifications
![certificat_1](https://www.vitaltech.bio/wp-content/uploads/2021/05/1-2.png)
![certificat_1](https://www.vitaltech.bio/wp-content/uploads/2021/05/2-2.png)
![certificat_1](https://www.vitaltech.bio/wp-content/uploads/2021/05/3-2.png)
![certificat_1](https://www.vitaltech.bio/wp-content/uploads/2021/05/4-2.png)